Vycor Medical (VYCO) Change in Receivables (2010 - 2026)
Vycor Medical (VYCO) reported Change in Receivables of -$16510.0 for Q1 2026, down 4.19% year-over-year from -$17232.1 in Q1 2025, and up 84.59% quarter-over-quarter from -$107161.0 in Q4 2025.
Vycor Medical (VYCO) Change in Receivables (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Change in Receivables data on file, last reported at -$16510.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at -$16510.0, down 4.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24342.0 (down 50.77% YoY), and the FY2025 annual result was -$23678.0, down 170.88% from the prior year.
- Change in Receivables grew to -$16510.0 in Q1 2026 per VYCO's latest filing, from -$107161.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $126074.0 in Q3 2025 and troughed at -$107161.0 in Q4 2025.
- A 5-year average of $4844.2 and a median of -$15566.0 in 2024 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 909.93% in 2025 and fell as far as 1733.55% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$24354.0 in 2022, then tumbled by 64.39% to -$40035.0 in 2023, then jumped by 116.39% to $6560.0 in 2024, then sank by 1733.55% to -$107161.0 in 2025, then jumped by 84.59% to -$16510.0 in 2026.
- Business Quant data shows VYCO's Change in Receivables at -$16510.0 in Q1 2026, -$107161.0 in Q4 2025, and $126074.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | -16,510.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,510.00 |
| Mar 31, 2026 | -16,510.00 |
| Dec 31, 2025 | -107,161.00 |
| Dec 31, 2025 | -107,161.00 |
| Sep 30, 2025 | 126,074.00 |
| Sep 30, 2025 | 126,074.00 |
| Jun 30, 2025 | -26,745.00 |
| Jun 30, 2025 | -26,745.00 |
| Mar 31, 2025 | -15,846.00 |
| Mar 31, 2025 | -15,846.00 |
| Dec 31, 2024 | 6,560.00 |
| Dec 31, 2024 | 6,560.00 |
| Sep 30, 2024 | -15,566.00 |
| Sep 30, 2024 | -15,566.00 |
| Jun 30, 2024 | 8,707.00 |
| Jun 30, 2024 | 8,707.00 |
| Mar 31, 2024 | 33,703.00 |
| Mar 31, 2024 | 33,703.00 |
| Dec 31, 2023 | -40,035.00 |
| Dec 31, 2023 | -40,035.00 |